Zoetis Services LLC.

Company Snapshot

Founded: 2013
Entity Type: Public
Employees: 14,500
Region: U.S.
Revenue: $9,467.0 Millions
Revenue Year: 2025
Headquarter: New Jersey, U.S.
Key Geographics: U.S., International
Corporate Address: 10 Sylvan Way, Parsippany, New Jersey 07054 U.S. Tel. +1-973-822-7000 www.zoetis.com

Company Overview

Zoetis Services LLC is an animal health company that offers medicines, vaccines, diagnostics, biodevices, genetic tests, and a range of services. It was incorporated in Delaware in July 2012, and before that, it was a business unit of Pfizer Inc.

Zoetis Services LLC sells products across eight core species: dogs, cats, and horses (collectively, companion animals) and cattle, swine, poultry, fish, and sheep (collectively, livestock); and within seven major product categories: parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceuticals, and animal health diagnostics. Animal health diagnostics include portable blood and urine analysis systems and point-of-care diagnostic products, including instruments and reagents, rapid immunoassay tests, reference laboratory kits, and blood glucose monitors. Its products are sold in over 100 countries, with direct presence in approximately 45.

Financial Highlights (FY 2025)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Zoetis Services LLC. In Reports

Global Veterinary Medical Devices Market

Explore the veterinary medical device market, covering diagnostic imaging, monitoring devices, surgical tools, and growing animal healthcare demand.

Global Markets for Animal Therapeutics and Diagnostics

BCC Research Market Report says global market for animal therapeutics and diagnostics is estimated to increase from $61.0 billion in 2023 to reach $81.2 billion by 2028, at a CAGR of 5.9%.

Veterinary Vaccines: Global Markets

According to BCC Research Report The global veterinary vaccines market reached $9.1 billion in 2022 should reach $9.6 billion by 2023 and $14.2 billion by 2028 with a CAGR of 8.2%.

Company's Business Segments

  • Companion Animal : Vaccines and Medicines for Dogs and Cats, Horses.
  • Livestock : Vaccines and Medicines for Cattle, Poultry, Swine, Fish, Sheep and Others.

Applications/End User Industries

  • Parasiticides
  • Vaccines
  • Dermatology
  • Anti Infectives
  • Pain and Sedation
  • Animal Health Diagnostics
  • Medicated Feed Additives
  • Life Sciences
AI Sentiment